Breaking News

  • Vaibhavi M.

Sapience Therapeutics Achieves Phase 2 Milestone for Lucicebtide in Newly Diagnosed Glioblastoma
Breaking News

More News

FDA Issues Draft Guidance on Platform CMC Knowledge to Streamline Gene Therapy Submissions

FDA Issues Draft Guidance on Platform CMC Knowledge to Streamline Gene...

Vaibhavi M.

HealthPartners Neuroscience Center Receives FDA Warning Letter Over GLP Mixture Uniformity Failures

HealthPartners Neuroscience Center Receives FDA Warning Letter Over GL...

Vaibhavi M.

Karyopharm Achieves Phase 3 SENTRY Primary Endpoint for Selinexor-Ruxolitinib Combination in Myelofibrosis

Karyopharm Achieves Phase 3 SENTRY Primary Endpoint for Selinexor-Ruxo...

Vaibhavi M.

Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman MD to Board Ahead of Cytisinicline NDA Resubmission

Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman MD to B...

Vaibhavi M.

Ad
Advertisement

Interviews & Opinions

Article

“If You Want to Be a King, First Behave Like One” Naresh Kumar Gaur on Leadership & Ownership

Naresh Kumar Gaur says pharma titles follow behaviour, not the other way around. Why most professionals are waiting for a crown they have to earn firs...

FT - Mr. Naresh Kumar Gaur

Read More

Article
From ‘Why Reject?’ to ‘How Release?’: Deepak Kasbi on the Cultural Shift in Pharma Quality

FT - Mr. Deepak Kasbi

Article
Five Pillars Of Leadership That Built A Pharma Veteran: Shyam Khante’s 45-Year Pharma Journey

FT - Mr. Shyam Khante

Article
“Quality is Driven by Science” – Leadership Lessons from Zydus President Vikram Shukla

FT - Mr. Vikram Shukla

Ad
Advertisement
Ad